Innovations in Clinical Development Keys to Success: Innovation, Diverse Talent, and Leadership
Virtual - Zoom
Tuesday, March 01, 2022
7:00 PM - 8:30 PM
Add to Calendar
Eastern Standard Time
Please join us for the second in our three-part series that is focused on introducing HBA members to the evolution of the life sciences industry over the past 20 years, and the leading role that Boston has played in it. Starting with The Human Genome Project, the latest cutting-edge innovations in genetic editing, precision medicines and AI all contribute to advancing the development of treatments for chronic and rare diseases. This series of HBA programs will explore what has driven the great strides made in therapeutic and disease advancement as well as how to adapt to the realities and dynamics of clinical development today.
In this event, Nina Wachsman, CEO and founder of KnowRare, will moderate a panel of experts from varied sectors to gain their diverse perspectives on the successes and challenges in the development of therapies for rare diseases. She will be joined by Katherine Beaverson, Senior Director and Patient Advocacy Lead, Rare Disease Research Unit, Pfizer; Julie Ross, President, Advanced Clinical; and Dr. Pushpa Narayanaswami MD, FAAN Vice- Chair, Clinical Operations, Dept. of Neurology, Beth Israel Deaconess Medical Center; Associate Professor of Neurology Harvard Medical School. This panel will discuss the keys to successful and timely delivery of much needed medicines to patients.